Rocket Pharmaceuticals
RCKT
#8013
Rank
NZ$0.62 B
Marketcap
NZ$5.76
Share price
-1.32%
Change (1 day)
10.49%
Change (1 year)

Earnings for Rocket Pharmaceuticals (RCKT)

Earnings in 2026 (TTM): -NZ$0.36 Billion

According to Rocket Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.39 Billion, an increase over its 2024 earnings that were of -NZ$0.45 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rocket Pharmaceuticals from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.36 Billion-7.1%
2025 -NZ$0.39 Billion-13.77%
2024 -NZ$0.45 Billion5.35%
2023 -NZ$0.43 Billion10.7%
2022 -NZ$0.39 Billion31.23%
2021 -NZ$0.3 Billion21.02%
2020 -NZ$0.25 Billion80.79%
2019 -NZ$0.14 Billion3.69%
2018 -NZ$0.13 Billion323.4%
2017 -NZ$30.24 Million-58.93%
2016 -NZ$73.63 Million-36.96%
2015 -NZ$0.12 Billion613.27%
2014 -NZ$16.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.26 Billion-28.41%๐Ÿ‡บ๐Ÿ‡ธ USA